The role of glucocorticoids and corticotropin-releasing hormone regulation on anxiety symptoms and response to treatment

  • Raglan G
  • Schmidt L
  • Schulkin J
N/ACitations
Citations of this article
102Readers
Mendeley users who have this article in their library.

Abstract

The stress response has been linked to the expression of anxiety and depression, but the mechanisms for these connections are under continued consideration. The activation and expression of glucocorticoids and CRH are variable and may hold important clues to individual experiences of mood disorders. This paper explores the interactions of glucocorticoids and CRH in the presentation of anxiety and depressive disorders in an effort to better describe their differing roles in each of these clinical presentations. In addition, it focuses on ways in which extra-hypothalamic glucocorticoids and CRH, often overlooked, may play important roles in the presentation of clinical disorders.

Cite

CITATION STYLE

APA

Raglan, G. B., Schmidt, L. A., & Schulkin, J. (2017). The role of glucocorticoids and corticotropin-releasing hormone regulation on anxiety symptoms and response to treatment. Endocrine Connections, 6(2), R1–R7. https://doi.org/10.1530/ec-16-0100

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free